Study of Silodosin to Facilitate Passage of Urinary Stones
Public ClinicalTrials.gov record NCT01144949. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled Study of Silodosin to Facilitate Urinary Stone Passage
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess if patients treated with silodosin will have a higher spontaneous passage rate of their ureteral stone than those treated with placebo.
Study identification
- NCT ID
- NCT01144949
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 239 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- Jul 2012 (Actual)
- Completion
- Jul 2012 (Actual)
- Last update posted
- Aug 11, 2014
2010 – 2012
United States locations
- U.S. sites
- 27
- U.S. states
- 13
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Watson Investigational Site | Birmingham | Alabama | — | — |
| Watson Investigational Site | Anchorage | Alaska | — | — |
| Watson Investigative Site | Mission Hills | California | — | — |
| Watson Investigational Site | Murrieta | California | — | — |
| Watson Investigational Site | San Diego | California | — | — |
| Watson Investigational Site | Daytona Beach | Florida | — | — |
| Watson Investigational Site | Gainesville | Florida | — | — |
| Watson Investigational Site | Orange City | Florida | — | — |
| Watson Investigative Site | Overland Park | Kansas | — | — |
| Watson Investigative Site | North Kansas City | Missouri | — | — |
| Watson Investigational Site | Hackensack | New Jersey | — | — |
| Watson Investigational Site | Mount Laurel | New Jersey | — | — |
| Watson Investigational Site | Sewell | New Jersey | — | — |
| Watson Investigational Site | Voorhees Township | New Jersey | — | — |
| Watson Investigational Site | Albany | New York | — | — |
| Watson Investigational Site | Garden City | New York | — | — |
| Watson Investigational Site | New York | New York | — | — |
| Watson Investigational Site | Plainview | New York | — | — |
| Watson Investigational Site | Syracuse | New York | — | — |
| Watson Investigational Site | Cincinnati | Ohio | — | — |
| Watson Investigational Site | Columbus | Ohio | — | — |
| Watson Investigational Site | Bala-Cynwyd | Pennsylvania | — | — |
| Watson Investigational Site | Lancaster | Pennsylvania | — | — |
| Watson Investigational Site | Myrtle Beach | South Carolina | — | — |
| Watson Investigational Site | Dallas | Texas | — | — |
| Watson Investigational Site | San Antonio | Texas | — | — |
| Watson Investigational Site | Virginia Beach | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01144949, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2014 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01144949 live on ClinicalTrials.gov.